Noiiglutide
A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.
Hengrui · Phase 2 · Completed · Enrollment 128
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.